SE0002232D0 - Antioxidant - Google Patents

Antioxidant

Info

Publication number
SE0002232D0
SE0002232D0 SE0002232A SE0002232A SE0002232D0 SE 0002232 D0 SE0002232 D0 SE 0002232D0 SE 0002232 A SE0002232 A SE 0002232A SE 0002232 A SE0002232 A SE 0002232A SE 0002232 D0 SE0002232 D0 SE 0002232D0
Authority
SE
Sweden
Prior art keywords
tyrosyl
gly
disease
group
analogues
Prior art date
Application number
SE0002232A
Other languages
English (en)
Inventor
Uelo Langel
Ursel Soomets
Eero Vasar
Mihkel Zilmer
Original Assignee
Vulpes Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vulpes Ltd filed Critical Vulpes Ltd
Priority to SE0002232A priority Critical patent/SE0002232D0/sv
Publication of SE0002232D0 publication Critical patent/SE0002232D0/sv
Priority to AU2001274745A priority patent/AU2001274745A1/en
Priority to PCT/SE2001/001351 priority patent/WO2001096369A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0002232A 2000-06-15 2000-06-15 Antioxidant SE0002232D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0002232A SE0002232D0 (sv) 2000-06-15 2000-06-15 Antioxidant
AU2001274745A AU2001274745A1 (en) 2000-06-15 2001-06-14 Gluthione analogues and their use as antioxidants
PCT/SE2001/001351 WO2001096369A1 (en) 2000-06-15 2001-06-14 Gluthione analogues and their use as antioxidants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002232A SE0002232D0 (sv) 2000-06-15 2000-06-15 Antioxidant

Publications (1)

Publication Number Publication Date
SE0002232D0 true SE0002232D0 (sv) 2000-06-15

Family

ID=20280094

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002232A SE0002232D0 (sv) 2000-06-15 2000-06-15 Antioxidant

Country Status (3)

Country Link
AU (1) AU2001274745A1 (sv)
SE (1) SE0002232D0 (sv)
WO (1) WO2001096369A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1617844A4 (en) * 2003-04-03 2009-07-22 Prana Biotechnology Ltd TREATMENT OF NEUROLOGICAL DISEASES
KR101592068B1 (ko) 2013-11-08 2016-02-05 순천향대학교 산학협력단 플라즈마 아포리포프로테인 h를 포함하는 아스피린 과민성 호흡계 질환 및 아스피린 내성 천식 구별 진단용 마커 및 구별 진단용 키트
BR112023012422A2 (pt) 2021-01-24 2023-12-12 Michael David Forrest Inibidores da atp sintase - usos cosmético e terapêutico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3568775D1 (en) * 1984-06-22 1989-04-20 Nattermann A & Cie S-(carbamoyl-phenylselenyl) derivatives of glutathion and of amino mercaptocarboxylic acids, process for their preparation and pharmaceutical preparations containing them
US5599903A (en) * 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics

Also Published As

Publication number Publication date
AU2001274745A1 (en) 2001-12-24
WO2001096369A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
WO2002048183A3 (en) Compositions of peptide crystals
IL122754A0 (en) Cyclosporin derivatives their preparation and pharmaceutical compositions containing them
NZ333609A (en) Peptide inhibitors of the interaction between P35 and MDM2 and the treatment of tumor cells
ES2160485A1 (es) Peptidos inhibidores de la exorcitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
HK1043475A1 (en) Compositions and methods for treating infections using analogues of indolicidin
ATE206716T1 (de) Cyclische wirkstoff-vorläufer verbindungen von peptiden und peptid-nukleicsäuren mit verbesserter metabolischer stabilität und zellmembran permeabilität
ATE513847T1 (de) Bioaktive peptide
BR9910639A (pt) Drogas anti-angiogênicas compreendendo peptìdeo
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
RU2223970C2 (ru) Лечение ожирения
ATE14226T1 (de) Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
TWI415628B (zh) 包含具有非天然胺基酸之胜肽之組合物及其使用方法
FR2846883B1 (fr) Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide
SE0002232D0 (sv) Antioxidant
IL104574A (en) N-[[3,4-dichlorophenyl)amino] carbonyl]-2,3-dihydro benzofuran-5-sulfonamide its preparation and antitumor compositions containing it and uses thereof
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
GB1533077A (en) 4-substituted enkephalin derivatives
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
DE69430416D1 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
DE60215917D1 (de) Tripepide und tripepdid-derivte zur behandlung von neurodegenerativen erkrankungen
ATE156016T1 (de) Glattmuskelrelaxierende arzneizubereitungen
EP0124420A3 (en) Gastric secretion inhibiting peptide derivatives, process for their preparation and medicines containing them
US7375085B1 (en) Melanocyte-stimulating hormone inhibitors
ES2088239T3 (es) Nuevos derivados peptidicos, procedimiento de preparacion y aplicacion como medicamentos de estos nuevos derivados.